Cagnoni Pablo J
- SEC CIK
- 0001205703
In the past year, 8 open-market sale filings worth $14.1M and no purchases.
Current role at each company
- INCY Incyte CorpPresident, Global Head of R&Das of Sep 17, 2026
- FUSN Fusion Pharmaceuticals Inc.Directoras of Jun 4, 2024
- RUBY Rubius Therapeutics, Inc.Directoras of Feb 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $14.1M
- 8 filings
- Net
- −$14.1M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cagnoni Pablo J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INCY Incyte Corp
President, Global Head of R&D8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)4:04 PM ET | Sep 15 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −23.2K | $120.49 | −$2.80M | −11.2%183.2K after | 2 lots10b5-1 |
| Aug 20, 2026 (view filing)5:15 PM ET | Aug 19 | 1 day | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.8K | $125.56 | −$1.36M | −5.6%183.2K after | 10b5-1 |
| Aug 14, 2026 (view filing)4:01 PM ET | Aug 12 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.8K | $120.04 | −$1.30M | −5.3%194.0K after | 10b5-1 |
| Aug 7, 2026 (view filing)4:02 PM ET | Aug 5 | 2 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −10.6K | $122.69 | −$1.31M | −4.9%204.8K after | 10b5-1 |
| Aug 4, 2026 (view filing)4:04 PM ET | Jul 31 | 4 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −15.9K | $119.70 | −$1.90M | −6.9%215.4K after | 10b5-1 |
| Apr 21, 2026 (view filing) | Apr 17 | 4 days | Cagnoni Pablo JPresident, Global Head of R&D | SSale | −18.7K | $96.50 | −$1.80M | −6.6%262.7K after | 10b5-1 |
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Cagnoni Pablo JPresident, R&D | SSale | −18.7K | $94.24 | −$1.76M | −7.4%234.8K after | 10b5-1 |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | Cagnoni Pablo JPresident, R&D | SSale | −18.7K | $100.91 | −$1.88M | −7.4%234.8K after | 10b5-1 |
RUBY Rubius Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 (view filing)9:41 PM ET | Feb 1 | Same day | Cagnoni Pablo JDirector | SSale | −8.45K | $0.25 | −$2.11K | −11.3%66.1K after | |
| Jan 31, 2023 (view filing)9:51 PM ET | Jan 31 | Same day | Cagnoni Pablo JDirector | SSale | −7.24K | $0.241 | −$1.74K | −8.9%74.5K after | |
| Feb 1, 2022 (view filing) | Feb 1 | Same day | Cagnoni Pablo JCEO and President | SSale | −6.73K | $6.57 | −$44.2K | −15.9%35.5K after |